Champalimaud Cancer Center Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00433589
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Champalimaud Foundation | Fundacao Champalimaud

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 5